Live Breaking News & Updates on Secondary Efficacy

Stay updated with breaking news from Secondary efficacy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

VALOR-HCM: Novel Drug May Delay, Avert Invasive Therapy in OHCM

A medical alternative to highly invasive septal reduction therapy for patients with obstructive hypertrophic cardiomyopathy and symptoms despite standard meds? Perhaps, a randomized trial suggests. ....

United States , Vanderbilt University , John Cleveland , Milindy Desai , University Of Colorado , American College Of Cardiology , Cleveland Clinic , American College , Secondary Efficacy , Safety Endpoint Results ,